RxDoctor Payments Data

Charles Kirkland, MD

Family Medicine · Fairhope, ALNPI 1669646147

Payments from drug & device makers

$16,132in general payments, 2019–2025

Across 910 payments — averaging $17.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Lilly USA, LLC$2K
  • Novo Nordisk$2K
  • Pfizer$1K
  • AstraZeneca$921
  • Johnson & Johnson$880
  • plus $7K from 54 others

What the payments were for

  • Food & beverage$16,02399%
  • Education$1091%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)139$2,266
Lilly USA, LLC99$1,755
Novo Nordisk119$1,735
Pfizer66$1,062
AstraZeneca42$921
Johnson & Johnson(2 entities)46$880
Bayer31$710
Merck41$596
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC26$536
Boehringer Ingelheim24$392
Amgen25$387
Antares Pharma, Inc.20$351
Takeda Pharmaceuticals U.S.A., Inc.21$329
Axsome Therapeutics, Inc.15$311
Novartis18$263
Corcept Therapeutics7$232
Amarin Pharma, Inc.10$213
Otsuka America Pharmaceutical, Inc.12$213
Corium, LLC11$198
Ironshore Pharmaceuticals Inc.6$187
Mylan Specialty L.p.6$163
Tris Pharma Inc9$150
Neos Therapeutics, LP8$149
Paratek Pharmaceuticals, Inc.2$143
Biohaven Pharmaceuticals, Inc.7$126
GSK7$116
Clarus Therapeutics Inc.2$108
Astellas Pharma US Inc3$106
Phathom Pharmaceuticals, Inc.9$96
Lundbeck LLC4$95
Supernus Pharmaceuticals, Inc.5$78
Biohaven Pharmaceutical Holding Company Ltd.4$76
Idorsia Pharmaceuticals US Inc4$73
Esperion Therapeutics, Inc.5$73
Sanofi-aventis U.S. LLC3$61
Boston Scientific2$58
Currax Pharmaceuticals LLC4$56
Teva Pharmaceuticals USA, Inc.4$56
Exact Sciences3$56
Shire North American Group Inc4$52
Optinose US, Inc.3$52
Tolmar, Inc.3$52
Sumitomo Pharma America, Inc.3$51
Inspire Medical Systems, Inc.1$50
Sanofi Pasteur Inc.3$49
Abbott2$40
Jazz Pharmaceuticals Inc.2$38
Viatris Specialty LLC2$36
Seqirus USA Inc1$32
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)1$27
Shield Therapeutics Inc1$26
Hikma Pharmaceuticals USA2$26
Avanir Pharmaceuticals, Inc.1$24
Halozyme Inc1$23
Eisai Inc.1$21
Xeris Pharmaceuticals, Inc.1$20
Aytu Biopharma, Inc.1$18
Bristol Myers Squibb1$18
Medtronic1$18
Ironwood Pharmaceuticals, Inc1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,132 in reported general payments places this provider in the 95th percentile of 1,680 family medicine providers in Alabama.

See all family medicine providers in Alabama

Medicare billing

Part B allowed, 2024
$72,796
Medicare patients
208
Services billed
19,715

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide88$119,289
EliquisApixaban31$29,838
OzempicSemaglutide12$27,053
JardianceEmpagliflozin15$25,497
Trelegy ElliptaFluticasone/Umeclidin/Vilanter17$23,675
KerendiaFinerenone19$23,393
Janumet XrSitagliptin Phos/Metformin Hcl14$23,218
EntrestoSacubitril/Valsartan18$14,766
XareltoRivaroxaban14$9,667
MyrbetriqMirabegron15$9,367
Omeprazole173$2,917
Atorvastatin Calcium219$2,654
Gabapentin102$2,234
Tamsulosin Hcl111$1,937
Duloxetine Hcl71$1,860

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$1,755$119,28988 claims
PfizerEliquis$1,062$29,83831 claims
Novo NordiskOzempic$1,735$27,05312 claims
Boehringer IngelheimJardiance$392$25,49715 claims
GSKTrelegy Ellipta$116$23,67517 claims
BayerKerendia$710$23,39319 claims
MerckJanumet Xr$596$23,21814 claims
NovartisEntresto$263$14,76618 claims
Johnson & JohnsonXarelto$880$9,66714 claims
Astellas Pharma US IncMyrbetriq$106$9,36715 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,680 family medicine providers in Alabama.

Other family medicine in Fairhope

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →